CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Pharmacovigilance of drug allergy and hypersensitivity using the ENDA-DAHD database and the GA2LEN platform. The Galenda project
Authors
P.-J. Bousquet Demoly, P. Romano, A. Aberer, W. Bircher, A. Blanca, M. Brockow, K. Pichler, W. Torres, M.J. Terreehorst, I. Arnoux, B. Atanaskovic-Markovic, M. Barbaud, A. Bijl, A. Bonadonna, P. Burney, P.G. Caimmi, S. Canonica, G.W. Cernadas, J. Dahlen, B. Daures, J.-P. Fernandez, J. Gomes, E. Gueant, J.-L. Kowalski, M.L. Kvedariene, V. Mertes, P.-M. Martins, P. Nizankowska-Mogilnicka, E. Papadopoulos, N. Ponvert, C. Pirmohamed, M. Ring, J. Salapatas, M. Sanz, M.L. Szczeklik, A. Van Ganse, E. De Weck, A.L. Zuberbier, T. Merk, H.F. Sachs, B. Sidoroff, A.
Publication date
1 January 2009
Publisher
Abstract
Nonallergic hypersensitivity and allergic reactions are part of the many different types of adverse drug reactions (ADRs). Databases exist for the collection of ADRs. Spontaneous reporting makes up the core data-generating system of pharmacovigilance, but there is a large under-estimation of allergy/hypersensitivity drug reactions. A specific database is therefore required for drug allergy and hypersensitivity using standard operating procedures (SOPs), as the diagnosis of drug allergy/hypersensitivity is difficult and current pharmacovigilance algorithms are insufficient. Although difficult, the diagnosis of drug allergy/hypersensitivity has been standardized by the European Network for Drug Allergy (ENDA) under the aegis of the European Academy of Allergology and Clinical Immunology and SOPs have been published. Based on ENDA and Global Allergy and Asthma European Network (GA2LEN, EU Framework Programme 6) SOPs, a Drug Allergy and Hypersensitivity Database (DAHD®) has been established under FileMaker® Pro 9. It is already available online in many different languages and can be accessed using a personal login. GA2LEN is a European network of 27 partners (16 countries) and 59 collaborating centres (26 countries), which can coordinate and implement the DAHD across Europe. The GA2LEN-ENDA-DAHD platform interacting with a pharmacovigilance network appears to be of great interest for the reporting of allergy/hypersensitivity ADRs in conjunction with other pharmacovigilance instruments. © 2009 The Authors
Similar works
Full text
Available Versions
Pergamos : Unified Institutional Repository / Digital Library Platform of the National and Kapodistrian University of Athens
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:lib.uoa.gr:uoadl:3004409
Last time updated on 10/02/2023